(Q34373694)

1 August 2017

title

Agranulocytosis associated with dipyrone (metamizol). (English)

1 reference

1 August 2017

1 reference

Luisa Ibáñez

1

1 reference

1 August 2017

Xavier Vidal

series ordinal

2

1 reference

1 August 2017

Elena Ballarín

series ordinal

3

1 reference

1 August 2017

Joan-Ramon Laporte

series ordinal

4

1 reference

1 August 2017

language of work or name

1 reference

3 December 2004

1 reference

European Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

60

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

821-829

1 reference

The incidence of metamizole sodium-induced agranulocytosis in Poland

1 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-004-0836-Y

A population based case-cohort study of drug-induced anaphylaxis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-004-0836-Y

AGRANULOCYTOSIS INDUCED BY DIPYRONE, A HAZARDOUS ANTIPYRETIC AND ANALGESIC

21 January 2018

1 reference

12 December 2020

Drug-induced agranulocytosis, with special reference to aminophenazone. I. Adults

1 reference

12 December 2020

Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs

1 reference

12 December 2020

Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).

1 reference

12 December 2020

Agranulocytosis and pyrazolone

1 reference

12 December 2020

Agranulocytosis induced by cinepazide

1 reference

12 December 2020

Acquired haemolytic anaemia. I. Incidence and aetiology

1 reference

12 December 2020

The Incidence of Dipyrone-Induced Agranulocytosis in Greece during 1975

1 reference

12 December 2020

Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches

1 reference

12 December 2020

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

12 December 2020

Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis

1 reference

12 December 2020

Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Agranulocytosis caused by amidopyrine; an avoidable cause of death

1 reference

12 December 2020

Drug-induced Blood Dyscrasias in Sweden

1 reference

12 December 2020

Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.

1 reference

12 December 2020

Agranulocytosis and pyrazolone analgesics

1 reference

12 December 2020

The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study

1 reference

12 December 2020

Comparative safety evaluation of non-narcotic analgesics

1 reference

12 December 2020

Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach

1 reference

12 December 2020

European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study.

1 reference

12 December 2020

Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug

1 reference

12 December 2020

A population-based case-cohort study of drug-associated agranulocytosis

1 reference

12 December 2020

Blood dyscrasias and the relative safety of non-narcotic analgesics

1 reference

12 December 2020

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

10.1007/S00228-004-0836-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1027076193

0 references

1 reference